The Conversation (0)
Download our investor reports
Copyright 2023 © Dig Media Inc.
Your trusted source for investing success since 2007. Renowned for our market outlook reports and investing guides.
Your trusted source for investing success since 2007. Renowned for our market outlook reports and investing guides.
Satellos Bioscience Inc.
TSXV:MSCL
Press Releases
More Press Releases
Satellos Bioscience Inc is a regenerative medicine company dedicated to developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. Its lead program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation which Satellos has identified as a root cause of the progressive nature of this disease.
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.Â